Editas Medicine, Inc. short interest in 2025
In 2025, Editas Medicine, Inc.'s disclosed short interest ran from 23.20% of shares outstanding on 15 Jan 2025 to 11.60% on 31 Dec 2025, a change of -11.60 percentage points. The year's high was 23.20% on 15 Jan 2025 and its low 8.29% on 30 Sep 2025, averaging 12.51% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.22 days on 14 Feb 2025. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 23.20% (15 Jan 2025)
- End of year
- 11.60% (31 Dec 2025)
- Change
- -11.60 pp
- High
- 23.20% (15 Jan 2025)
- Low
- 8.29% (30 Sep 2025)
- Average
- 12.51%
- Highest days to cover
- 8.22 (14 Feb 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 23.20% | 6.70 | results (8-K) |
| 31 Jan 2025 | 20.70% | 8.12 | |
| 14 Feb 2025 | 21.12% | 8.22 | |
| 28 Feb 2025 | 16.59% | 1.13 | |
| 14 Mar 2025 | 15.85% | 4.16 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 15.29% | 7.25 | |
| 15 Apr 2025 | 15.27% | 5.04 | |
| 30 Apr 2025 | 13.99% | 7.27 | |
| 15 May 2025 | 10.96% | 4.79 | 10-Q filed, results (8-K) |
| 30 May 2025 | 10.84% | 5.31 | |
| 13 Jun 2025 | 10.16% | 3.76 | |
| 30 Jun 2025 | 10.52% | 2.74 | |
| 15 Jul 2025 | 10.26% | 2.49 | |
| 31 Jul 2025 | 9.46% | 2.99 | |
| 15 Aug 2025 | 9.12% | 3.63 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 8.69% | 7.28 | |
| 15 Sep 2025 | 8.41% | 5.44 | |
| 30 Sep 2025 | 8.29% | 2.36 | |
| 15 Oct 2025 | 8.47% | 2.17 | |
| 31 Oct 2025 | 8.88% | 2.97 | |
| 14 Nov 2025 | 10.25% | 4.99 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.83% | 7.88 | |
| 15 Dec 2025 | 11.43% | 6.36 | |
| 31 Dec 2025 | 11.60% | 6.50 |
See also: Editas Medicine, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.